U.S. Pharma Stock News

NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma (RPRX) Valuation Check After Strong Q1 Earnings And Rising Investor Interest

Royalty Pharma earnings and buyback catch investors’ attention Royalty Pharma (RPRX) has drawn fresh investor focus after reporting first quarter 2026 earnings with revenue of US$630.58 million and net income of US$294.69 million, alongside continued progress on its multi year share repurchase program. See our latest analysis for Royalty Pharma. The stock has picked up momentum, with a 1 day share price return of 3.0% and a year to date share price return of 37.03%, while the 1 year total...
NYSE:TDG
NYSE:TDGAerospace & Defense

Is It Time To Reassess TransDigm Group (TDG) After The Recent Share Price Pullback

This article looks at what the numbers indicate about whether TransDigm Group, at around US$1,201 per share, still offers value or whether most of the opportunity is already reflected in the price. The share price has fallen 2.6% over the last week and over the last 30 days, is down 11.6% year to date, and 7.7% over the past year, while the 3 year and 5 year returns stand at 71.4% and 146.0% respectively. Recent coverage of TransDigm Group has largely focused on its role within the broader...
NYSE:SUNB
NYSE:SUNBTrade Distributors

Sunbelt Rentals Holdings (SUNB) Valuation Check As US$1.5b Buyback Program Continues

Sunbelt Rentals Holdings buyback puts capital returns in focus Sunbelt Rentals Holdings (SUNB) recently repurchased 75,000 shares as part of its ongoing US$1.5b buyback program, a move that puts capital allocation and shareholder returns in the spotlight for investors. See our latest analysis for Sunbelt Rentals Holdings. At a share price of US$76.07, Sunbelt Rentals Holdings has logged a 1 month share price return of 9.86% and a year to date share price return of 14.25%. Its 1 year total...